Read Time:6 Second
Sales of Horizon’s thyroid eye-disease drug Tepezza have plateaued, a challenge its new owner will need to contend with.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
